GNAI2 and hepatocellular carcinoma: In in vitro experiments using many different types of tumors such as ovarian cancer cells, hepatocellular carcinoma, and tongue squamous cell carcinoma, gain-of-function mutations that led to the constant activation of GNAI2 have been identified in a number of cancers, which prompt the growth and survival of cancer cells [39].